761 related articles for article (PubMed ID: 26812284)
1. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
Dening TJ; Rao S; Thomas N; Prestidge CA
Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
[TBL] [Abstract][Full Text] [Related]
2. Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro.
Meola TR; Dening TJ; Prestidge CA
Eur J Pharm Biopharm; 2018 Aug; 129():145-153. PubMed ID: 29857135
[TBL] [Abstract][Full Text] [Related]
3. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
[TBL] [Abstract][Full Text] [Related]
4. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
Miao Y; Chen G; Ren L; Pingkai O
Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
[TBL] [Abstract][Full Text] [Related]
5. Impact of solidification on the performance of lipid-based colloidal carriers: oil-based versus self-emulsifying systems.
Alinaghi A; Tan A; Rao S; Prestidge CA
Curr Drug Deliv; 2015; 12(1):16-25. PubMed ID: 25030115
[TBL] [Abstract][Full Text] [Related]
6. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
Yasmin R; Tan A; Bremmell KE; Prestidge CA
J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
[TBL] [Abstract][Full Text] [Related]
7. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment.
Patel G; Shelat P; Lalwani A
Drug Deliv; 2016 Oct; 23(8):3027-3042. PubMed ID: 26882014
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
Nekkanti V; Wang Z; Betageri GV
AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability of lurasidone by self-nanoemulsifying drug delivery system in fasted state.
Miao Y; Sun J; Chen G; Lili R; Ouyang P
Drug Dev Ind Pharm; 2016 Aug; 42(8):1234-40. PubMed ID: 26582334
[TBL] [Abstract][Full Text] [Related]
10. Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate.
Bajaj A; Rao MR; Khole I; Munjapara G
Drug Dev Ind Pharm; 2013 May; 39(5):635-45. PubMed ID: 22564007
[TBL] [Abstract][Full Text] [Related]
11. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
[TBL] [Abstract][Full Text] [Related]
13. Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs.
Yasmin R; Rao S; Bremmell KE; Prestidge CA
AAPS J; 2016 Jul; 18(4):876-85. PubMed ID: 27048207
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
Thomas N; Holm R; Müllertz A; Rades T
J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
[TBL] [Abstract][Full Text] [Related]
15. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
[TBL] [Abstract][Full Text] [Related]
16. Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs.
Yasmin R; Rao S; Bremmell K; Prestidge C
Eur J Pharm Sci; 2017 Jan; 96():508-514. PubMed ID: 27793717
[TBL] [Abstract][Full Text] [Related]
17. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers.
Beg S; Swain S; Singh HP; Patra ChN; Rao ME
AAPS PharmSciTech; 2012 Dec; 13(4):1416-27. PubMed ID: 23070560
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations.
Thombre AG; Shah JC; Sagawa K; Caldwell WB
Int J Pharm; 2012 May; 428(1-2):8-17. PubMed ID: 22349051
[TBL] [Abstract][Full Text] [Related]
19. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
[TBL] [Abstract][Full Text] [Related]
20. Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: Physicochemical characterization and in vivo evaluation.
Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Lee BJ; Park YJ; Yong CS; Kim JO; Choi HG
Colloids Surf B Biointerfaces; 2017 Feb; 150():216-222. PubMed ID: 27918966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
